For drug-device combination products, the compatibility of the drug and device components requires analysis of many factors. In this webcast, learn about regulations and drug-device compatibility assessment steps that are necessary to protect patients. Live: Tuesday, May 19, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until May 19, 2021.
Register Free: http://www.pharmtech.com/pt_w/access_compatibility
Event Overview:
Drug-device combination products offer options for the convenient delivery of drugs to patients. Because the patient frequently interacts with the drug and device, assessment of the compatibility of a device with certain drugs is crucial.
The compatibility of the drug and device components requires analysis of many different aspects including drug stability, chemical compatibility, and biocompatibility. These aspects need to be in balance to establish a healthy relationship within the combined products and to avoid any danger to the patient.
In this webcast, learn about the necessity of a good relationship between the drug and the device for the benefit of the patient.
Key Learning Objectives:
During this 40-minute webcast, will review the following:
Speakers: Lise Vanderkelen, PhD, Pharmaceuticals and Microbiology Expert, Nelson Labs Europe, a Sotera Health Company
Ruth Verplaetse, PhD, Study Director, Nelson Labs Europe, a Sotera Health Company
Time and Date: Tuesday, May 19, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until May 19, 2021.
Sponsor: Nelson Labs
Register Free: http://www.pharmtech.com/pt_w/access_compatibility